Chemed Corporation (NYSE:CHE) Receives $498.00 Average Price Target from Analysts

Shares of Chemed Corporation (NYSE:CHE) have been assigned a consensus rating of “Hold” from the six brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among brokers that have covered the stock in the last year is $498.00.

Several brokerages have commented on CHE. Oppenheimer dropped their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Zacks Research cut shares of Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a research note on Friday, February 27th.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 3.29% of the stock is currently owned by corporate insiders.

Institutional Trading of Chemed

Institutional investors have recently added to or reduced their stakes in the stock. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed during the fourth quarter worth approximately $26,000. Smartleaf Asset Management LLC grew its stake in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the period. BOK Financial Private Wealth Inc. acquired a new stake in shares of Chemed in the fourth quarter worth $27,000. Finally, First Horizon Corp purchased a new position in shares of Chemed in the 3rd quarter valued at $31,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

NYSE CHE opened at $380.46 on Friday. Chemed has a 52-week low of $365.20 and a 52-week high of $623.60. The firm’s 50 day moving average price is $422.33 and its 200-day moving average price is $433.38. The company has a market cap of $5.24 billion, a PE ratio of 20.71, a P/E/G ratio of 1.50 and a beta of 0.49.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). The business had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, analysts forecast that Chemed will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio is currently 13.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.